Preliminary reports show conolidine may possibly inhibit certain ion channels, minimizing neuronal excitability and restricting suffering signals. This mechanism is particularly applicable in neuropathic agony, exactly where abnormal signaling leads to persistent discomfort. Moreover, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to soreness percept... https://johnu579lzo8.wikilinksnews.com/user